7 insiders reported 10 Form 4 transactions for Kairos Pharma, LTD. (KAPA) over the past 18 months (most recent 2025-12-30). Recent activity: Bhowmick Neil (Chief Scientific Officer) Buy 171,756 shares, Bae Hyun W. (Director) Buy 10,000 shares, Bae Hyun W. (Director) Buy 19,084 shares, Keyoung Hansoo Michael (Director) Buy 19,084 shares, Murali Ramachandran (VP of Research and Development) Buy 152,672 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-30 | Bhowmick Neil | Chief Scientific Officer | Buy | 171,756 | $0 |
| 2025-12-23 | Bae Hyun W. | Director | Buy | 10,000 | $0 |
| 2025-12-23 | Bae Hyun W. | Director | Buy | 19,084 | $0 |
| 2025-11-26 | Keyoung Hansoo Michael | Director | Buy | 19,084 | $0 |
| 2025-11-26 | Murali Ramachandran | VP of Research and Development | Buy | 152,672 | $0 |
| 2025-11-26 | Samuelson Doug | Chief Financial Officer | Buy | 152,672 | $0 |
| 2025-11-26 | Singhvi Rahul | Director | Buy | 19,084 | $0 |
| 2025-11-26 | Yu John S | CEO and Chairman | Buy | 190,840 | $0 |
| 2025-11-26 | Keyoung Hansoo Michael | Director | Buy | 10,000 | $0 |
| 2025-04-07 | Bhowmick Neil | Chief Scientific Officer | Buy | 14,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2025-12-30